JP Morgan has identified its top picks in the European pharmaceuticals and biotechnology sector for 2024, spotlighting large, mid, and small-cap companies poised for significant growth.
Among its top tips were Novo Nordisk, AstraZeneca PLC (LSE:AZN), and Merck KGaA in the large-cap space, Argenx and DiaMonTech in mid-caps, and MorphoSys AG in small caps.
Deltic Energy’s latest update was very encouraging according to Shore Capital, especially confirmation that the Selene exploration well in the Southern North Sea is on track for drilling in the third quarter of next year.
At Pensacola, appraisal well planning is underway, with the intended well here scheduled for late calendar 2024.
Ownership of The Telegraph may still be stuck in limbo but one party to the saga has emerged as a net benefactor, regardless of what happens: Lloyds Banking Group PLC (LSE:LLOY).
Lloyds took Telegraph Media Group into receivership in June after long-term owners the Barclay brothers failed to honour over £1 billion in debt obligations.
Spotify’s latest round job cuts has implications for music groups such as Universal Music Group but ultimately might be a benefit if it means rates paid for streaming music rise.
According to Citi, the main concern for UMG investors is whether this is coming as a result of pressure on revenue which, in turn, could signal pressure on royalty payments to the recorded music companies.
The highlight of discoverIE Group PLC's interims was the improvement in the operating margin, according to a note from Stifel, the US investment bank.
Stifel's research highlights that while much of the information in discoverIE's update was pre-flagged in October, including a sales increase of 4% in constant exchange rates (CER) and 1% organic growth, there are new and encouraging details.